Edwards Lifesciences Corp
(WBO:EWLS)
€
58.61
-0.01 (-0.02%)
Market Cap: 35.75 Bil
Enterprise Value: 34.58 Bil
PE Ratio: 26.95
PB Ratio: 5.30
GF Score: 78/100 Edwards Lifesciences Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 13, 2020 / 09:00PM GMT
Release Date Price:
€67.22
(-1.70%)
Robert Adam Hopkins
BofA Merrill Lynch, Research Division - MD of Equity Research
Okay. Good afternoon, everybody, and welcome to the last fireside chat of the day, at least from a medical technology perspective. This is Bob Hopkins from Bank of America. Very excited to have our next discussion with management team from Edwards Lifesciences. On the line with me, we have Scott Ullem, who everybody knows is the company's Chief Financial Officer; also Mark Wilterding and Oliver from Investor Relations. And thank you for joining us today. We really appreciate your time, and we're going to kind of do entirely a fireside chat.
So Scott, Mark, Oliver, thanks so much for joining me today.
Scott B. Ullem
Edwards Lifesciences Corporation - Corporate VP & CFO
Yes, it's our pleasure. Thanks for having us, Bob. We've been looking forward to this.
Questions & Answers
Robert Adam Hopkins
BofA Merrill Lynch, Research Division - MD of Equity Research
Yes, absolutely. And so maybe we'll just sort of jump
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot